BioSpace News Archive

Blue Water Vaccines, Inc., a privately held company, announced today that the company has entered into an option agreement with the University of Oxford in the United Kingdom providing Blue Water Vaccines the option to exclusively license a novel and potentially revolutionary universal influenza vaccine.

Berger Montague announced today that Alkermes (NASDAQ: ALKS) and its CEO and CFO have been accused of federal securities law violations in a class action filed in the U.S. District Court for the Eastern District of New York.

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for DEXTENZA (dexamethasone ophthalmic insert

Can “borrowed” drugs for treating other diseases protect the skin in patients with lupus? Can researchers coax the body to weed out harmful immune cells that drive tissue destruction in lupus?

Shepherd Search Group is excited to announce the expansion of their Life Sciences Division. Ed Canning, an industry leader, has been appointed Managing Director of Shepherd’s Regulatory Affairs Team

RFPi Inc. has received 510(k) clearance from the U.S. Food and Drug Administration to begin marketing for use by surgeons in open surgery its iCertainty™ blood flow and perfusion imaging medical device.

Growing emphasis on early detection and prevention is driving the melanoma cancer diagnostics market, with global revenue surpassing US$ 800 million in 2018, according to a new study conducted by Fact.MR.

Neurologics has announced the appointment of Howard Dell to its Board of Advisors.

Seven transactions involved sellers with net revenues over $1 billion, signaling continued focus on strategic over opportunistic growth

Report finds that “While the VNA, in and of itself, is not a comprehensive enterprise image strategy, it will come to be considered a key component”